source
- Patient dies in Bristol Myers Squibb autoimmune CAR-T trial, raising safety concernsBristol Myers Squibb reported that a participant in its Phase 1 CAR-T study for multiple sclerosis died. The trial was testing an investigational CAR-T therapy aimed at autoimmune disease. The pat…
- EQT to acquire Qiagen in €10.8 billion dealEQT, a private‑equity firm, announced it will purchase Dutch molecular diagnostics company Qiagen in a transaction valued at €10.8 billion, including €1.1 billion of net debt. The deal follows a f…